Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer Journal Article


Authors: Wohlhieter, C. A.; Richards, A. L.; Uddin, F.; Hulton, C. H.; Quintanal-Villalonga, À; Martin, A.; de Stanchina, E.; Bhanot, U.; Asher, M.; Shah, N. S.; Hayatt, O.; Buonocore, D. J.; Rekhtman, N.; Shen, R.; Arbour, K. C.; Donoghue, M.; Poirier, J. T.; Sen, T.; Rudin, C. M.
Article Title: Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer
Abstract: Concurrent loss-of-function mutations in STK11 and KEAP1 in lung adenocarcinoma (LUAD) are associated with aggressive tumor growth, resistance to available therapies, and early death. We investigated the effects of coordinate STK11 and KEAP1 loss by comparing co-mutant with single mutant and wild-type isogenic counterparts in multiple LUAD models. STK11/KEAP1 co-mutation results in significantly elevated expression of ferroptosis-protective genes, including SCD and AKR1C1/2/3, and resistance to pharmacologically induced ferroptosis. CRISPR screening further nominates SCD (SCD1) as selectively essential in STK11/KEAP1 co-mutant LUAD. Genetic and pharmacological inhibition of SCD1 confirms the essentiality of this gene and augments the effects of ferroptosis induction by erastin and RSL3. Together these data identify SCD1 as a selective vulnerability and a promising candidate for targeted drug development in STK11/KEAP1 co-mutant LUAD. © 2020 The Author(s) Wohlhieter et al. explore the global changes in gene expression and oncogenic signaling pathways driven by concurrent loss of function in two tumor suppressor genes, STK11 and KEAP1. They identify a molecular vulnerability, in which co-mutant cells depend on ferroptosis protective mechanisms for survival, and highlight SCD1 as an essential gene and promising drug target. © 2020 The Author(s)
Keywords: nsclc; ferroptosis; crispr; lkb1; stk11; keap1; akr1c1; scd1
Journal Title: Cell Reports
Volume: 33
Issue: 9
ISSN: 2211-1247
Publisher: Cell Press  
Date Published: 2020-12-01
Start Page: 108444
Language: English
DOI: 10.1016/j.celrep.2020.108444
PUBMED: 33264619
PROVIDER: scopus
PMCID: PMC7722473
DOI/URL:
Notes: Article -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    434 Rekhtman
  2. Ronglai Shen
    206 Shen
  3. Umeshkumar Kapaldev Bhanot
    93 Bhanot
  4. Marina Asher
    36 Asher
  5. Charles Rudin
    495 Rudin
  6. Nisargbhai Sanjaykumar Shah
    29 Shah
  7. Kathryn Cecilia Arbour
    89 Arbour
  8. Axel Stephen Martin
    20 Martin
  9. Christopher Hulton
    7 Hulton
  10. Triparna Sen
    56 Sen
  11. Fathema Zannath Uddin
    22 Uddin
  12. Omar Hayatt
    5 Hayatt